## **Core Concept**
The treatment of well-differentiated thyroid cancer (WDTC), which includes papillary and follicular thyroid cancers, often involves surgery, radioactive iodine (RAI) therapy, and thyroid hormone suppression therapy. The management approach depends on the stage, patient age, and other risk factors.

## **Why the Correct Answer is Right**
is used in the treatment of well-differentiated thyroid cancer because it helps in ablating any residual thyroid tissue and microscopic disease that might remain after surgery. This is particularly important for facilitating the use of thyroglobulin as a tumor marker for recurrence and for allowing the detection of recurrence with radioactive iodine scans.

## **Why Each Wrong Option is Incorrect**
* **Option A:** - This option is incorrect because, although might be considered in certain contexts, it is not the primary treatment for well-differentiated thyroid cancer.
* **Option B:** - This option is incorrect as it does not directly relate to a standard treatment approach for WDTC.
* **Option D:** - This option is incorrect because it is not specifically used for the treatment of well-differentiated thyroid cancer.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that radioactive iodine therapy is particularly useful for its dual role in WDTC: (1) ablation of residual normal thyroid tissue, which facilitates follow-up, and (2) treatment of iodine-avid metastatic disease.

## **Correct Answer:** .